AdventHealth Medical Group Advanced Lung Disease ( Site 1058) — Orlando, Florida

AdventHealth Medical Group Advanced Lung Disease ( Site 1058) is a clinical research site located in Orlando, Florida, United States 32804.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

AdventHealth Medical Group Advanced Lung Disease ( Site 1058) has participated in 2 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AdventHealth Medical Group Advanced Lung Disease ( Site 1058)?

AdventHealth Medical Group Advanced Lung Disease ( Site 1058) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AdventHealth Medical Group Advanced Lung Disease ( Site 1058) conducted?

AdventHealth Medical Group Advanced Lung Disease ( Site 1058) has 2 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is AdventHealth Medical Group Advanced Lung Disease ( Site 1058) accredited by Crixeo Health?

AdventHealth Medical Group Advanced Lung Disease ( Site 1058) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AdventHealth Medical Group Advanced Lung Disease ( Site 1058)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.